PLIN2: a potential prognostic markers of early-stage atypical endometrial hyperplasia. [PDF]
Lian C +6 more
europepmc +1 more source
Fertility-sparing treatment for overweight patients with early-stage endometrial cancer or atypical endometrial hyperplasia under weight loss intervention. [PDF]
Fu M +8 more
europepmc +1 more source
Development of a clinical diagnostic model for atypical endometrial hyperplasia and endometrial carcinoma in women aged 40-60 years based on refined abnormal uterine bleeding patterns. [PDF]
Huang S +5 more
europepmc +1 more source
A deep learning-based computer-aided diagnosis system for detecting atypical endometrial hyperplasia and endometrial cancer through hysteroscopy. [PDF]
Wang W +9 more
europepmc +1 more source
The association of molecular classification with fertility-sparing treatment of atypical endometrial hyperplasia and endometrial cancer: a retrospective study. [PDF]
Wang Y +5 more
europepmc +1 more source
Diagnostic Value of ADC in Distinguishing Endometrial Cancer from Atypical Endometrial Hyperplasia and Within Molecular Subtypes. [PDF]
Xu S +6 more
europepmc +1 more source
Uterine-Conserving Treatment Options for Atypical Endometrial Hyperplasia and Early Endometrial Cancer. [PDF]
Adjei NN +4 more
europepmc +1 more source
Metabolic syndrome combined with insulin resistance showed great predictive value in evaluating recurrence in patients with atypical endometrial hyperplasia and early endometrial cancer. [PDF]
Wu Y, Wang J, Fan Y, Wang J, Li X.
europepmc +1 more source
The value of diffusion-weighted imaging and semi-quantitative dynamic contrast-enhanced MRI in predicting the efficacy of medroxyprogesterone acetate treatment for atypical endometrial hyperplasia and endometrial carcinoma. [PDF]
Liu M +5 more
europepmc +1 more source

